You are here

Home › Listings › Life Sciences › FSD Pharma Inc. Subordinate Voting Shares

FSD Pharma Inc. Subordinate Voting Shares

Listing Exchange: 
CSE
Status: 
Active
Industry: 
Life Sciences
Symbol: 
HUGE
CSE Index: 
Currency: 

FSD Pharma Inc. is a biopharmaceutical company developing three clinical candidates with the potential to address neuropsychiatric, neurodegenerative and inflammatory disorders. The three licensed drug candidates are LUCID-MS, a new chemical entity targeting Multiple Sclerosis, LUCID-PSYCH, a psychoactive molecule targeting Major Depressive Disorder, and FSD-PEA, an ultra-micronized Palmitoyl ethylamine with a favorable safety profile targeting inflammation.

 

You are here

Home

FSD Pharma Inc. Subordinate Voting Shares (HUGE)

SEDAR Information

Search form

Company Info

Address
199 Bay Street
Suite 4000
Toronto, ON M5L 1A9
Canada
Phone
844-978-3540
Email
info@fsdpharma.com
Website
https://www.fsdpharma.com
Listing date
Tuesday, May 29, 2018
Transfer Agent
Marrelli Trust Company Limited
Investor Relations
Zeeshan Saeed
Email
IR@fsdpharma.com
Auditor
MNP LLP

Capitalization

Issued & Outstanding: 
40090849
Reserved for Issuance: 
54580587

Company Officers

Anthony Durkacz, Founder & Executive Co-Chairman
Zeeshan Saeed, Founder & Executive Co-Chairman

News Releases

22/04/2024

FSD Pharma Provides Another Update on Celly Nu's Anticipated Launch of unbuzzd(TM)

17/04/2024

FSD Pharma Expands Investigative Pipeline to Include Potential Weight Loss and Liver Health Formulations and Products

Bulletins

27/11/2023

2023-1133 - Reclassification - FSD Pharma Inc. Subordinate Voting Shares (HUGE)

le 27 Novembre/November 2023

CSE Filings

HUGE - CSE form 7 - March 2024

HUGE - CSE form 7 - February 2024

HUGE - Notice of Proposed Stock Options

HUGE - Notice of Proposed Issuance of Securities

FSD Pharma Inc. - Form 8 - NOTICE OF PROPOSED PROSPECTUS OFFERING